PARP抑制剂
前列腺癌
奥拉帕尼
BRCA2蛋白
医学
聚ADP核糖聚合酶
癌症
DNA修复
内科学
癌症研究
生物
突变
基因
遗传学
种系突变
聚合酶
作者
Qi Ye,Bohan Ma,Lei Li,Zixi Wang,Mingming Lu,Jialu Kang,Yuzeshi Lei,Shan Xu,Ke Wang,Yanlin Jian,Yizeng Fan,Bin Wang,Jing Liu,Yang Gao,Jian Ma,Lei Li
出处
期刊:Cancer Research
[American Association for Cancer Research]
日期:2025-07-29
卷期号:85 (18): 3490-3502
被引量:1
标识
DOI:10.1158/0008-5472.can-24-4096
摘要
BPD is a peptide-based PROTAC that effectively degrades BRCA2, selectively accumulates in tumor cells, reduces homologous recombination efficiency, and enhances sensitivity to PARP inhibitors in prostate cancer.
科研通智能强力驱动
Strongly Powered by AbleSci AI